These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26027616)

  • 1. Recidivism to uncontrolled blood pressure in patients with previously controlled hypertension.
    Sandhu A; Ho PM; Asche S; Magid DJ; Margolis KL; Sperl-Hillen J; Rush B; Price DW; Ekstrom H; Tavel H; Godlevsky O; O'Connor PJ
    Am Heart J; 2015 Jun; 169(6):791-7. PubMed ID: 26027616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications.
    Porter AK; Taylor SR; Yabut AH; Al-Achi A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):905-11. PubMed ID: 25166289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in blood pressure control within a community-based provider network: an exploratory analysis.
    Romanelli RJ; Schiro TA; Jukes T; Wong KS; Ishisaka DY
    Ann Pharmacother; 2011 Dec; 45(12):1473-82. PubMed ID: 22147145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension control: how well are we doing?
    Borzecki AM; Wong AT; Hickey EC; Ash AS; Berlowitz DR
    Arch Intern Med; 2003 Dec 8-22; 163(22):2705-11. PubMed ID: 14662624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
    Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
    Blood Press; 2008; 17(1):7-17. PubMed ID: 18568687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
    Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
    Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
    Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics.
    Duggirala MK; Cuddihy RM; Cuddihy MT; Naessens JM; Cha SS; Mandrekar JN; Leibson CL
    Am J Hypertens; 2005 Jun; 18(6):833-8. PubMed ID: 15925744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
    Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
    QJM; 2013 Oct; 106(10):909-14. PubMed ID: 23696676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The joint association of physical activity, blood-pressure control, and pharmacologic treatment of hypertension for all-cause mortality risk.
    Brown RE; Riddell MC; Macpherson AK; Canning KL; Kuk JL
    Am J Hypertens; 2013 Aug; 26(8):1005-10. PubMed ID: 23690165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures.
    Vigen R; Shetterly S; Magid DJ; O'Connor PJ; Margolis KL; Schmittdiel J; Ho PM
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):276-82. PubMed ID: 22576846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study.
    Lehmann MV; Zeymer U; Dechend R; Kaiser E; Hagedorn I; Deeg E; Senges J; Schmieder RE
    Int J Cardiol; 2013 Oct; 168(3):2255-63. PubMed ID: 23474245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
    Santschi V; Rodondi N; Bugnon O; Burnier M
    Eur J Intern Med; 2008 Oct; 19(6):427-34. PubMed ID: 18848176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
    Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
    J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for uncontrolled hypertension in Italy.
    Degli Esposti E; Di Martino M; Sturani A; Russo P; Dradi C; Falcinelli S; Buda S
    J Hum Hypertens; 2004 Mar; 18(3):207-13. PubMed ID: 14973516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.